I agree that this site is using cookies. You can find further informations here.
X
Allez, M.
~ 200  results:
Search for persons X
?
1

French protocol for the diagnosis and management of hematop..:

Farge, D. ; Pugnet, G. ; Allez, M....
La Revue de Médecine Interne.  45 (2024)  2 - p. 79-99 , 2024
Link: https://doi.org/10.1016/..
 
?
2

P903 Persistence, efficacy and tolerance of subcutaneous In..:

Mathieu, N ; Heluwaert, F ; Riviere, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1655-i1655 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P277 Interobserver agreement of current and new proposed en..:

Bak, M ; Hammoudi, N ; Allez, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i644-i644 , 2024
Link: https://doi.org/10.1093/..
 
?
4

DOP65 Infliximab plus azathioprine and quick steroids disco..:

Amiot, A ; Seksik, P ; Meyer, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i191-i191 , 2024
Link: https://doi.org/10.1093/..
 
?
5

P165 Guselkumab binding to CD64+ IL-23–producing myeloid ce..:

Atreya, R ; Abreu, M T ; Krueger, J G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i470-i470 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P900 A PROOF-OF-CONCEPT, PLACEBO-RANDOMIZED CONTROLLED TRIA..:

Carbonnel, F ; Barnich, N ; Hébuterne, X...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1650-i1650 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P504 Guselkumab, an IL-23p19 subunit–specific monoclonal an..:

Atreya, R ; Abreu, M T ; Krueger, J G...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i634-i635 , 2023
Link: https://doi.org/10.1093/..
 
?
8

DOP89 Impact of biologics on the risk of early postoperativ..:

Fumery, M ; Nancey, S ; Nachury, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i166-i167 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P515 Infliximab desensitization in patients with Inflammato..:

Hammoudi, N ; Hassid, D ; Bonnet, J...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i643-i643 , 2023
Link: https://doi.org/10.1093/..
 
?
10

Prognosis and molecular characteristics of IBD-associated c..:

Hammoudi, N. ; Lehmann-Che, J. ; Lambert, J....
Digestive and Liver Disease.  55 (2023)  9 - p. 1280-1287 , 2023
Link: https://doi.org/10.1016/..
 
?
11

OP13 Postoperative Crohn's disease recurrence: unanswered q..:

Riviere, P ; Dragoni, G ; Allez, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i18-i19 , 2023
Link: https://doi.org/10.1093/..
 
?
12

P404 Persistence of subcutaneous infliximab after switching..:

Mathieu, N ; Riviere, P ; Heluwaert, F...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i533-i534 , 2023
Link: https://doi.org/10.1093/..
 
?
13

P132 Prognosis and molecular characteristics of IBD-associa..:

Hammoudi, N ; Lehmann-Che, J ; Lambert, J...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i296-i297 , 2023
Link: https://doi.org/10.1093/..
 
?
14

DOP42 Efficacy of etrasimod on symptomatic relief in patien..:

Chaparro, M ; Armuzzi, A ; Irving, P M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i107-i110 , 2023
Link: https://doi.org/10.1093/..
 
?
15

P540 Longitudinal Dynamics of Gut Microbiome and Metabolome..:

Ahmed, M ; Metwaly, A ; Hammoudi, N...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i488-i489 , 2022
Link: https://doi.org/10.1093/..
 
1-15